October 24, 2022
Gulf Coast Biologics Training and Education Center, Fort Myers FL, headed by Peter Everts, Ph.D., FRSM, is dedicated to providing the latest advancements in autologous regenerative medicine treatment options to physicians, practitioners, and health care providers across the globe. Many of those advances are increasingly dependent upon capturing and analyzing the large amounts of real-world data generated by everyday clinical cases.
With the help of RegenMed, and key Gulf Coast Faculty members, such as Luga Podesta, M.D. and Glenn Flanagan, M.D., Gulf Coast Biologics will design and implement engaging, flexible, and collaborative data registries. Each registry will be condition-specific, and will make real-world data capture simple, burden-free, and engaging for providers and research faculty.
Key elements of this initiative include:
If you are interested in learning more about Gulf Coast Biologics, or about its Real-World Evidence Registries, please contact Peter Everts at email@example.com.
March 28, 2023
Statistical Significance and Clinical Relevance are two important concepts in the field of medicine, and particularly in clinical research. Being a bit more specific, statistical significance refers to the likelihood that a result is not due to chance.
March 17, 2023
Real-world evidence (RWE) is valuable not only for regulatory compliance, clinical decision-making and tracking adverse events. It can also drive patient engagement, profitability and professional advancement.
January 27, 2023
In this newsletter, we summarize the work of leading physicians as they develop clinical decision support for common musculoskeletal pathologies. Through the quality improvement and pragmatic studies embedded in their Circles, those clinicians are generating sustained financial and professional value for themselves, and improving patient care, with minimum burden. Moreover, their Circles are often supported by industry.